Daniel Chung

Daniel Chung

Company: SparingVision

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Maximizing Patient Enrollment for Gene Therapy Trials & Strategies for Commercial Success 2:30 pm

Learn effective methods for identifying and enrolling patients in rare disease trials to enhance trial efficiency Discover how to balance recruitment strategies with the need to ensure the therapy’s long-term commercial viability Explore innovative approaches using technology, partnerships, and advocacy groups to boost patient recruitment and retention ratesRead more

day: Day 2- Clinical 2

Case Study: Building Natural History Data for Rare Disorders to Improve Existing Strategies for Gene Therapy Development 12:30 pm

Leveraging patient registries, electronic health records (EHRs), and patient-reported outcomes to gather natural history data quickly and cost-effectively Using natural history data to define clinical endpoints, establish baseline variability, and select appropriate patient populations for trials Identifying and validating surrogate endpoints that can predict clinical benefit, facilitate regulatory interactions, and enable faster market accessRead more

day: Day 1- Clinical 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.